O'Connor Donal

O'Connor Donal is listed in filings as Director at Theravance Biopharma, Inc.. This profile follows SEC Form 4 activity through Jun 16, 2026, including 12 public disclosures. Recent filings connect the profile to Theravance Biopharma, Inc. (TBPH) and Perrigo Co PLC (PRGO). The current snapshot covers public activity from May 16, 2025 to Jun 16, 2026. Reported amounts are shown as $222.9K to $123.7K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.